{"id":"https://openalex.org/W1988100739","doi":"https://doi.org/10.1002/pds.677","title":"Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports","display_name":"Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports","publication_year":2001,"publication_date":"2001-10-01","ids":{"openalex":"https://openalex.org/W1988100739","doi":"https://doi.org/10.1002/pds.677","mag":"1988100739","pmid":"https://pubmed.ncbi.nlm.nih.gov/11828828"},"language":"en","primary_location":{"id":"doi:10.1002/pds.677","doi":"https://doi.org/10.1002/pds.677","is_oa":false,"landing_page_url":"https://doi.org/10.1002/pds.677","pdf_url":null,"source":{"id":"https://openalex.org/S140231191","display_name":"Pharmacoepidemiology and Drug Safety","issn_l":"1053-8569","issn":["1053-8569","1099-1557"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacoepidemiology and Drug Safety","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060735505","display_name":"Stephen Evans","orcid":"https://orcid.org/0000-0002-1474-2596","observed_orcids":["https://orcid.org/0000-0002-1474-2596"]},"institutions":[{"id":"https://openalex.org/I2802373619","display_name":"Government of the United Kingdom","ror":"https://ror.org/05wnh3t63","country_code":"GB","type":"government","lineage":["https://openalex.org/I2802373619"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"S. J. W. Evans","raw_affiliation_strings":["Post-Licensing Division, Medicines Control Agency, Market Towers, 1, Nine Elms Lane, London SW8 5NQ","Post\u2010Licensing Division, Medicines Control Agency, Market Towers, 1, Nine Elms Lane, London SW8 5NQ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Post-Licensing Division, Medicines Control Agency, Market Towers, 1, Nine Elms Lane, London SW8 5NQ","institution_ids":["https://openalex.org/I2802373619"]},{"raw_affiliation_string":"Post\u2010Licensing Division, Medicines Control Agency, Market Towers, 1, Nine Elms Lane, London SW8 5NQ","institution_ids":["https://openalex.org/I2802373619"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111772790","display_name":"PATRICK C. WALLER","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802373619","display_name":"Government of the United Kingdom","ror":"https://ror.org/05wnh3t63","country_code":"GB","type":"government","lineage":["https://openalex.org/I2802373619"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"P. C. Waller","raw_affiliation_strings":["Post-Licensing Division, Medicines Control Agency, Market Towers, 1, Nine Elms Lane, London SW8 5NQ","Post\u2010Licensing Division, Medicines Control Agency, Market Towers, 1, Nine Elms Lane, London SW8 5NQ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Post-Licensing Division, Medicines Control Agency, Market Towers, 1, Nine Elms Lane, London SW8 5NQ","institution_ids":["https://openalex.org/I2802373619"]},{"raw_affiliation_string":"Post\u2010Licensing Division, Medicines Control Agency, Market Towers, 1, Nine Elms Lane, London SW8 5NQ","institution_ids":["https://openalex.org/I2802373619"]}]},{"author_position":"last","author":{"id":null,"display_name":"S. Davis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802373619","display_name":"Government of the United Kingdom","ror":"https://ror.org/05wnh3t63","country_code":"GB","type":"government","lineage":["https://openalex.org/I2802373619"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"S. Davis","raw_affiliation_strings":["Post-Licensing Division, Medicines Control Agency, Market Towers, 1, Nine Elms Lane, London SW8 5NQ","Post\u2010Licensing Division, Medicines Control Agency, Market Towers, 1, Nine Elms Lane, London SW8 5NQ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Post-Licensing Division, Medicines Control Agency, Market Towers, 1, Nine Elms Lane, London SW8 5NQ","institution_ids":["https://openalex.org/I2802373619"]},{"raw_affiliation_string":"Post\u2010Licensing Division, Medicines Control Agency, Market Towers, 1, Nine Elms Lane, London SW8 5NQ","institution_ids":["https://openalex.org/I2802373619"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5111772790"],"corresponding_institution_ids":["https://openalex.org/I2802373619"],"apc_list":{"value":4650,"currency":"USD","value_usd":4650},"apc_paid":null,"fwci":19.719,"has_fulltext":false,"cited_by_count":1803,"citation_normalized_percentile":{"value":0.99872935,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"10","issue":"6","first_page":"483","last_page":"486"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11819","display_name":"Data-Driven Disease Surveillance","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11649","display_name":"Pharmaceutical industry and healthcare","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/proportional-reporting-ratio","display_name":"proportional reporting ratio","score":0.9769999980926514},{"id":"https://openalex.org/keywords/drug-safety-signals","display_name":"drug safety signals","score":0.7450000047683716},{"id":"https://openalex.org/keywords/spontaneous-adverse-drug-reaction-reporting","display_name":"spontaneous adverse drug reaction reporting","score":0.7940000295639038},{"id":"https://openalex.org/keywords/pharmacovigilance","display_name":"pharmacovigilance","score":0.652999997138977},{"id":"https://openalex.org/keywords/newly-marketed-drugs","display_name":"newly marketed drugs","score":0.8519999980926514},{"id":"https://openalex.org/keywords/signal-generation","display_name":"signal generation","score":0.35199999809265137},{"id":"https://openalex.org/keywords/drug-safety-assessment","display_name":"drug safety assessment","score":0.3059999942779541}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8396402597427368},{"id":"https://openalex.org/C13424479","wikidata":"https://www.wikidata.org/wiki/Q5687237","display_name":"Haystack","level":2,"score":0.7204012870788574},{"id":"https://openalex.org/C2780542314","wikidata":"https://www.wikidata.org/wiki/Q45959","display_name":"Adverse drug reaction","level":3,"score":0.6354944109916687},{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.5536061525344849},{"id":"https://openalex.org/C23276603","wikidata":"https://www.wikidata.org/wiki/Q158230","display_name":"Pharmacoepidemiology","level":3,"score":0.5174777507781982},{"id":"https://openalex.org/C2993432071","wikidata":"https://www.wikidata.org/wiki/Q45959","display_name":"Drug reaction","level":3,"score":0.5160841345787048},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5087972283363342},{"id":"https://openalex.org/C2777105317","wikidata":"https://www.wikidata.org/wiki/Q4686710","display_name":"Adverse Event Reporting System","level":3,"score":0.45277151465415955},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.41678228974342346},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.39722439646720886},{"id":"https://openalex.org/C77088390","wikidata":"https://www.wikidata.org/wiki/Q8513","display_name":"Database","level":1,"score":0.3930453062057495},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2832265794277191},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.28269141912460327},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.13745319843292236},{"id":"https://openalex.org/C154945302","wikidata":"https://www.wikidata.org/wiki/Q11660","display_name":"Artificial intelligence","level":1,"score":0.128239244222641},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D003627","descriptor_name":"Data Interpretation, Statistical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003627","descriptor_name":"Data Interpretation, Statistical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003627","descriptor_name":"Data Interpretation, Statistical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012984","descriptor_name":"Software","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012984","descriptor_name":"Software","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012984","descriptor_name":"Software","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016208","descriptor_name":"Databases, Factual","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016208","descriptor_name":"Databases, Factual","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016208","descriptor_name":"Databases, Factual","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016907","descriptor_name":"Adverse Drug Reaction Reporting Systems","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D016907","descriptor_name":"Adverse Drug Reaction Reporting Systems","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D016907","descriptor_name":"Adverse Drug Reaction Reporting Systems","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/pds.677","doi":"https://doi.org/10.1002/pds.677","is_oa":false,"landing_page_url":"https://doi.org/10.1002/pds.677","pdf_url":null,"source":{"id":"https://openalex.org/S140231191","display_name":"Pharmacoepidemiology and Drug Safety","issn_l":"1053-8569","issn":["1053-8569","1099-1557"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacoepidemiology and Drug Safety","raw_type":"journal-article"},{"id":"pmid:11828828","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11828828","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacoepidemiology and drug safety","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8560000061988831,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.7200000286102295,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":8,"referenced_works":["https://openalex.org/W1942992998","https://openalex.org/W1982161744","https://openalex.org/W2091815199","https://openalex.org/W2109974875","https://openalex.org/W2111632643","https://openalex.org/W2506153346","https://openalex.org/W4285719527","https://openalex.org/W4323284481"],"related_works":["https://openalex.org/W2380396032","https://openalex.org/W157859230","https://openalex.org/W2377282230","https://openalex.org/W2908992680","https://openalex.org/W2331399373","https://openalex.org/W2995438986","https://openalex.org/W3811925","https://openalex.org/W2939597317","https://openalex.org/W4283278517","https://openalex.org/W2520672216"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1,61,124,144],"process":[2],"of":[3,6,63,76,100,119,141,159],"generating":[4],"'signals'":[5],"possible":[7],"unrecognized":[8],"hazards":[9],"from":[10,199],"spontaneous":[11,200],"adverse":[12,166],"drug":[13,68],"reaction":[14],"reporting":[15,190,201],"data":[16,33,202],"has":[17],"been":[18,35],"likened":[19],"to":[20,31,52,66,80,128,174,177,196,206],"looking":[21],"for":[22,71,84,107],"a":[23,26,49,56,67,72,91,98,108,193],"needle":[24],"in":[25,87,90,134],"haystack.":[27],"However,":[28],"statistical":[29,50],"approaches":[30],"the":[32,39,81,88,135,138,150,154,178],"have":[34,45],"under-utilised.":[36],"METHODS:":[37],"Using":[38],"UK":[40],"Yellow":[41],"Card":[42],"database,":[43,89],"we":[44],"developed":[46],"and":[47,181,208,210],"evaluated":[48],"aid":[51,195],"signal":[53,197],"generation":[54,198],"called":[55],"Proportional":[57,189],"Reporting":[58],"Ratio":[59],"(PRR).":[60],"proportion":[62,83],"all":[64,85],"reactions":[65],"which":[69,171,203],"are":[70,192,204,213],"particular":[73],"medical":[74],"condition":[75],"interest":[77],"is":[78],"compared":[79],"same":[82],"drugs":[86,102,132],"2":[92,94],"x":[93],"table.":[95],"We":[96],"investigated":[97],"group":[99],"newly-marketed":[101,133],"using":[103],"as":[104],"minimum":[105,151],"criteria":[106,152],"signal,":[109],"3":[110],"or":[111],"more":[112],"cases,":[113],"PRR":[114],"at":[115,120],"least":[116,121],"2,":[117],"chi-squared":[118],"4.":[122],"FINDINGS:":[123],"database":[125],"was":[126],"used":[127],"examine":[129],"retrospectively":[130],"15":[131],"UK,":[136],"with":[137],"highest":[139],"levels":[140],"ADR":[142],"reporting.":[143],"method":[145],"identified":[146],"481":[147],"signals":[148,184],"meeting":[149],"during":[153],"period":[155],"1996-8.":[156],"Further":[157],"evaluation":[158],"these":[160],"showed":[161],"that":[162],"70%":[163],"were":[164,169,172,183],"known":[165],"reactions,":[167],"13%":[168],"events":[170],"likely":[173],"be":[175],"related":[176],"underlying":[179],"disease":[180],"17%":[182],"requiring":[185],"further":[186],"evaluation.":[187],"IMPLICATIONS:":[188],"ratios":[191],"valuable":[194],"easy":[205],"calculate":[207],"interpret,":[209],"various":[211],"refinements":[212],"possible.":[214]},"counts_by_year":[{"year":2026,"cited_by_count":258},{"year":2025,"cited_by_count":294},{"year":2024,"cited_by_count":220},{"year":2023,"cited_by_count":109},{"year":2022,"cited_by_count":79},{"year":2021,"cited_by_count":82},{"year":2020,"cited_by_count":76},{"year":2019,"cited_by_count":64},{"year":2018,"cited_by_count":56},{"year":2017,"cited_by_count":52},{"year":2016,"cited_by_count":40},{"year":2015,"cited_by_count":46},{"year":2014,"cited_by_count":58},{"year":2013,"cited_by_count":65},{"year":2012,"cited_by_count":50}],"updated_date":"2026-10-15T10:00:46.086208","created_date":"2016-06-24T00:00:00"}